Cargando…
A decade of increases in Medicare Part B pharmaceutical spending: what are the drivers?
BACKGROUND: Medicare Part B pharmaceutical spending has increased rapidly, more than doubling in 2006-2017. Yet, it is unclear whether this increase was driven by increased utilization or increased cost per claim. OBJECTIVE: To evaluate the relative impact of changes in drug utilization and cost per...
Autores principales: | San-Juan-Rodriguez, Alvaro, Gellad, Walid F, Shrank, William H, Good, Chester B, Hernandez, Inmaculada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906185/ https://www.ncbi.nlm.nih.gov/pubmed/33908276 http://dx.doi.org/10.18553/jmcp.2021.27.5.565 |
Ejemplares similares
-
Trends in the Use of Conventional and New Pharmaceuticals for Hemophilia Treatments Among Medicaid Enrollees, 2005-2020
por: Hernandez, Inmaculada, et al.
Publicado: (2021) -
Trends in List Prices, Net Prices, and Discounts for Originator Biologics Facing Biosimilar Competition
por: San-Juan-Rodriguez, Alvaro, et al.
Publicado: (2019) -
Pharmaceutical Use and Spending Trend in Medicare Beneficiaries With Dementia, From 2006 to 2012
por: Hernandez, Inmaculada, et al.
Publicado: (2017) -
Trends in list prices, net prices, and discounts of self-administered injectable tumor necrosis factor inhibitors
por: San-Juan-Rodriguez, Alvaro, et al.
Publicado: (2021) -
Comparison of oral anticoagulation use and adherence among Medicare beneficiaries enrolled in stand-alone prescription drug plans vs Medicare Advantage prescription drug plans
por: Newman, Terri Victoria, et al.
Publicado: (2022)